This Week in HIV Research: The Perils of Polypharmacy
Posted Feb 16, 3:34 p.m. ET
The risks of multiple non-HIV medication prescriptions; PrEP use and sexually transmitted infection incidence; how vaginal bacteria relate to HIV seroconversion; the effect of early treatment on HIV in the brain.
Love Positive Women: Why a Fulfilling Sexual Life With HIV Matters
Allison Carter, Jessica Whitbread, and Angela Kaida, Canadian AIDS Treatment Information Exchange; Posted Feb 16, 1:09 p.m. ET
Although most attention is paid to preventing the transmission of HIV to intimate partners, women's sexual concerns go far beyond condom use.
U.S. Approve a Lower-Dose Efavirenz-Based Generic Fixed-Dose Combination (Symfi Lo)
Simon Collins, Mylan Laboratories, Ltd.; Posted Feb 15, 2:33 p.m. ET
On Feb. 7 2018, the U.S. FDA approved a new generic fixed-dose combination that uses a lower dose of Sustiva together with Epivir and Viread.
Homeless LGBTQ Youth Remain at Risk for HIV, and They Need Us
Giuliani Alvarenga, TheBody; Posted Feb 15, 1:16 p.m. ET
Homelessness is a problem in and of itself, but for LGBTQ youth, housing instability is also a significant risk factor for becoming HIV positive.
Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.
Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?
Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?
Bictegravir Approved in the U.S. in New Integrase Inhibitor-Based Fixed-Dose Combination (Biktarvy)
Simon Collins, HIV i-Base; Posted Feb 14, 9:58 p.m. ET
On Feb. 7, 2018, the U.S. FDA approved a new fixed-dose combination (FDC) containing bictegravir, emtricitabine and tenofovir alafenamide (TAF).
Getting Your Sexy On!!
The Well Project; Posted Feb 14, 2:56 p.m. ET
Does HIV make it hard for you to feel sexy or be intimate? Get some tips about how to boost your sex-esteem and put the pleasure back in sex!
Pregnancy and Infant Feeding: Can We Say U=U About the Risk of Passing HIV to an Infant?
Camille Arkell, Canadian AIDS Treatment Information Exchange; Posted Feb 14, 1:22 p.m. ET
An examination of what we know about the risk of passing HIV through pregnancy, childbirth, and infant feeding.
HIVMA Response to President's Budget Proposal
Melanie Thompson, HIV Medicine Association; Posted Feb 13, 2:40 p.m. ET
"The budget proposal released Monday by the Trump administration is long on talk of national safety, security and strength, but undermines funding and strategies to counter some of the most significant threats to our nation's health, stability and well-being."
My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.
Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.
In President Trump's New Budget, HIV Programs Are at Risk
Drew Gibson, Posted Feb 13, 1:15 p.m. ET
If it wasn't clear after President's Trump's bare-bones budget request last year, his fiscal 2019 budget request has left no doubt that people living with or affected by HIV are not a priority for his administration.
HIV Undetectable = Untransmittable (U=U): Information for Providers
New York City Department of Health and Mental Hygiene; Posted Feb 12, 9:56 p.m. ET
The basics for health care professionals covering the evidence for U=U, HIV prevention, and considerations for acheiving undetectable viral load.
San Francisco Will Be First U.S. City With Legal Injection Site to Prevent Opioid Overdoses; Others Scramble to Follow
Tim Murphy, TheBody; Posted Feb 12, 3:16 p.m. ET
Even as overdose deaths surge, the movement for "safe consumption" sites remains fraught with challenges.
This Week in HIV Research: When Prioritizing Treatment, Look Beyond CD4
TheBodyPRO; Posted Feb 12, 1:13 p.m. ET
Gauging treatment priority when CD4 count is high; the effect of hepatitis C coinfection on response to HIV treatment; HIV, aging and comorbidity in Africa; PrEP and drug-resistant gonorrhea.
>> Browse Older Featured Stories